Study With a Topical Gel to Treat Common Warts in Adults
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 88
- Registration Number
- NCT00117923
- Locations
- 🇺🇸
Oregon Medical Research Center, Portland, Oregon, United States
Study With a Topical Gel to Treat Common Warts in Adults
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT00117871
- Locations
- 🇺🇸
Minnesota Clinical Study Center, Fridley, Minnesota, United States
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-07-01
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 84
- Registration Number
- NCT00116662
- Locations
- 🇺🇸
Vermont, Burlington, Vermont, United States
🇺🇸Utah, Layton, Utah, United States
🇺🇸Massachusetts, Boston, Massachusetts, United States
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-07-01
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 84
- Registration Number
- NCT00116675
- Locations
- 🇺🇸
Longmont Clinic/Longmont Medical Research Network, Longmont, Colorado, United States
🇺🇸Mercy Health Research, St. Louis, Missouri, United States
🇺🇸Walla Walla Clinic, Walla Walla, Washington, United States
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
- First Posted Date
- 2005-07-01
- Last Posted Date
- 2010-07-20
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 551
- Registration Number
- NCT00116649
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-06-22
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 270
- Registration Number
- NCT00115154
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-06-22
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 88
- Registration Number
- NCT00115141
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-06-21
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 88
- Registration Number
- NCT00114920
- Locations
- 🇺🇸
Welborn Clinic, Evansville, Indiana, United States
A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling
Completed
- Conditions
- First Posted Date
- 2005-06-17
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 48
- Registration Number
- NCT00114673
1-Year Follow up to the 1473-IMIQ Study
Completed
- Conditions
- First Posted Date
- 2005-06-14
- Last Posted Date
- 2007-02-19
- Lead Sponsor
- Graceway Pharmaceuticals, LLC
- Target Recruit Count
- 84
- Registration Number
- NCT00114023
© Copyright 2024. All Rights Reserved by MedPath